Popular
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Harry Erba, MD, PhD
Rethinking Potassium Restriction in Chronic Kidney Disease Management
Clinician's RoundtableRethinking Potassium Restriction in Chronic Kidney Disease Management
Deborah Clegg, PhD
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 3
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 3
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Psoriasis and Mental Health: Why Whole-Patient Care Matters
On the Frontlines of PsoriasisPsoriasis and Mental Health: Why Whole-Patient Care Matters
Steve Jackson, PharmD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch.1
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch.1
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Programs
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Rethinking Potassium Restriction in Chronic Kidney Disease Management
Clinician's RoundtableRethinking Potassium Restriction in Chronic Kidney Disease Management
Deborah Clegg, PhD
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Psoriasis and Mental Health: Why Whole-Patient Care Matters
On the Frontlines of PsoriasisPsoriasis and Mental Health: Why Whole-Patient Care Matters
Steve Jackson, PharmD
Clinical Practice
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Harry Erba, MD, PhD
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
CardiologySPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Muthiah Vaduganathan, MD, MPH
Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
CardiologyTreatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
Andrew Patrick Ambrosy, MD, MPH
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual EventPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Doctors Lounge
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Brian P. McDonough, MD, FAAFP
Kate Rouch
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Clinician's RoundtableDisparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Navigating Vaccine Communication: A Medical Affairs Perspective
MAPSChatsNavigating Vaccine Communication: A Medical Affairs Perspective
Matt Birnholz, MD
Abigail Sporer, PhD, MBA
CME
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
- NEW EPISODE
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Industry Feature
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
Improving Preterm Birth Outcomes with Virtual Cervix Technology
Medical Industry FeatureImproving Preterm Birth Outcomes with Virtual Cervix Technology
Mirella Mourad, M.D.
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Medical Industry FeatureLong-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Arati Chand, MD
Bhumika Patel, MD
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Medical Industry FeatureAdvancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Jennifer Caudle, DO, FACOFP
Seth Wander, MD, PhD
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH